Measles continues to spread in Texas and other states and has caused the first reported U.S. death from the virus in a decade ...

GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also ...

Just over half of U.S. adults (53%) say they’ve gotten neither the flu shot nor the updated COVID-19 vaccine since last ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

As measles cases continue to spread across the United States, experts reveal who may need another vaccine dose and who is ...

The Centers for Disease Control and Prevention has added a new vaccine recommendation for adults. Those as young as age 50 should get vaccinated against pneumococcal pneumonia, the CDC said. The ...

U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024Obe-cel MHRA and ...

PEMGARDA (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 million; full-year 2024 net product revenue totaled $25.4 ...